Benjamin Hickey
CIK 1753055 · President, RayzeBio Org. · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.3K
Companies
5
Total Filings
35
Lifetime Open-Market Net
-$1.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CELGr | President, RayzeBio Org. | 18,344 | $0.12 | $2.3K | -$3.7K | 9 | 2026-03-12 |
| MURAV | Director | — | — | — | $0 | 5 | 2025-12-05 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | EVP, Chief Commercial Officer | 0 | $58.70 | $0 | -$1.85M | 16 | 2024-01-23 |
| Surface Oncology, Inc. (SURF) Delisted | Director | — | $1.07 | — | $0 | 2 | 2022-06-10 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, Chief Commerical Officer | 13,226 | — | — | $0 | 3 | 2019-10-01 |
Recent Filings · Page 2 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-03 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-03-12 | CELGr | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | CELGr | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −117,028 | $0 | EDGAR |
| 2024-01-18 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −1,597 | -$94.3K | EDGAR |
| 2024-01-09 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −2,090 | -$123.1K | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +17,021 | $1000.0K | EDGAR |
| 2023-12-18 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2023-12-14 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −2,220 | -$125.8K | EDGAR |
| 2023-08-10 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +22,297 | $825.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.